Gene regulation by BCL3 in a cervical cancer cell line

Folia Biologica

Volumn 56, Issue 4, 2010, Pages 183-193

  Maldonado, Vilma ^a,b   Espinosa, M ^b   Pruefer, F ^b   Patino N ^b   Ceballos Cancino, G ^b   Urzua, U ^c   Juretic, N ^c   Melendez Zajgla, Jorge ^b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

NF B; Signal transduction; STAT3

Indexed keywords

ACTIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN BCL 3; SHORT HAIRPIN RNA;

APOPTOSIS; ARTICLE; BCL3 GENE; CANCER CELL CULTURE; CANCER PATIENT; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE CONTROL; HUMAN; HUMAN CELL; ONCOGENE; PROTO ONCOGENE; RNA INTERFERENCE; STAT3 GENE; UPREGULATION; UTERINE CERVIX CANCER; VALIDATION PROCESS;

EID: 77956694481     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Aggarwal, B. B. (2004) Nuclear factor-κB: the enemy within. Cancer Cell 6, 203-208.
2. Bandala, E., Espinosa, M., Maldonado, V., Melendez-Zajgla, J. (2001) Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine. Biochem. Pharmacol. 62, 13-19.
3. Bauer, A., Villunger, A., Labi, V., Fischer,S. F., Strasser, A., Wagner, H., Schmid, R. M., Hacker, G. (2006) The NF-κB regulator Bcl3 and the BH3-only proteins Bim and Puma control the death of activated T cells. Proc. Natl. Acad. Sci. USA 103, 10979-10984.
4. Blobel, C. P. (2005) ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6, 32-43.
5. Brocke-Heidrich, K., Ge, B., Cvijic, H., Pfeifer, G., Loffler, D., Henze, C., McKeithan, T. W., Horn, F. (2006) BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription. Oncogene 25, 7297-7304.
6. Cogswell, P. C., Guttridge, D.C., Funkhouser, W.K., Baldwin, A.S., Jr. (2000) Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κ B2/p52 and for Bcl3. Oncogene 19, 1123-1131.
7. Cristofanon, S., Morceau, F., Scovassi, AI., Dicato, M., Ghibelli, L., Diederich, M. (2009) Oxidative, multistep activation of the noncanonical NF-κB pathway via disulfide Bcl3/p50 complex. FASEB J. 23, 45-57.
8. Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E. J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Gascoyne, R. D., Delabie, J., Rimsza, L. M., Braziel, R. M., Grogan, T. M., Campo, E., Jaffe, E. S., Dave, B. J., Sanger, W., Bast, M., Vose, J. M., Armitage, J. O., Connors, J. M., Smeland, E. B., Kvaloy, S., Holte, H., Fisher, R. I., Miller, T. P., Montserrat, E., Wilson, W. H., Bahl, M., Zhao, H., Yang, L., Powell, J., Simon, R., Chan, W. C., Staudt, L. M. (2006) Molecular diagnosis of Burkitt's lymphoma. N. Engl. J. Med. 354, 2431-2442.
9. Fujita, T., Nolan, G. P., Liou, H. C., Scott, M. L., Baltimore, D (1993) The candidate proto-oncogene Bcl3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev. 7, 1354-1363.
10. Gilmore, T. D (2006) Introduction to NF-κB: players, pathways, perspectives. Oncogene 25, 6680-6684.
11. Gough, D. J., Corlett, A., Schlessinger, K., Wegrzyn, J., Larner, A. C., Levy, D. E. (2009) Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 324, 1713-1716.
12. Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F., Bernd, H. W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., Hansmann, M. L., Haralambieva, E., Harder, L., Hasenclever, D., Kuhn, M., Lenze, D., Lichter, P., Martin-Subero, J. I., Moller, P., Muller-Hermelink, H. K., Ott, G., Parwaresch, R. M, Pott, C., Rosenwald, A., Rosolowski, M., Schwaenen, C., Sturzenhofecker, B., Szczepanowski, M., Trautmann, H., Wacker, H. H., Spang, R., Loeffler, M., Trumper, L., Stein, H., Siebert, R. (2006) A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N. Engl. J. Med. 354, 2419-2430.
13. Ji, H., Zhao, X., Yuza, Y., Shimamura, T., Li, D., Protopopov, A., Jung, B. L., McNamara, K., Xia, H., Glatt, K. A., Thomas, R. K., Sasaki, H., Horner, J. W., Eck, M., Mitchell, A., Sun, Y., Al-Hashem, R., Bronson, R. T., Rabindran, S. K., Discafani, C. M., Maher, E., Shapiro, G.I., Meyerson, M., Wong, K. K. (2006) Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors. Proc. Natl. Acad. Sci. USA 103, 7817-7822.
14. Kashatus, D., Cogswell, P., Baldwin, A. S. (2006) Expression of the Bcl3 proto-oncogene suppresses p53 activation. Genes Dev. 20, 225-235.
15. Konnikova, L., Simeone, M. C., Kruger, M. M., Kotecki, M., Cochran, B. H. (2005) Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells. Cancer Res. 65, 6516-6520.
16. Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A., Fassler, R. (2006) Cyld inhibits tumor cell proliferation by blocking Bcl3-dependent NF-κB signaling. Cell 125, 665-677.
17. Mendoza, J., Zamora, R., Gallardo, J. C., Ceballos, G., Aldana, A., Espinosa, M., Maldonado, V., Melendez-Zajgla, J. (2006) NF-κB does not influence the induction of apoptosis by ukrain. Cancer Biol. Ther. 5, 788-793.
18. Park, S. G., Chung, C., Kang, H., Kim, J. Y., Jung, G. (2006) Up-regulation of cyclin D1 by HBx is mediated by NF-κ B2/BCL3 complex through κB site of cyclin D1 promoter. J. Biol. Chem. 281, 31770-31777.
19. Perkins, N. D. (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62.
20. Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A., Chinnaiyan, A. M. (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1-6.
21. Rocha, S., Martin, A. M., Meek, D. W., Perkins, N. D. (2003) p53 represses cyclin D1 transcription through down regulation of Bcl3 and inducing increased association of the p52 NF-κB subunit with histone deacetylase 1. Mol. Cell Biol. 23, 4713-4727.
22. Spandidos, A., Wang, X., Wang, H., Dragnev, S., Thurber, T., Seed, B. (2008) A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundance. BMC Genomics 9, 633.
23. Thornburg, N. J., Pathmanathan, R., Raab-Traub, N. (2003) Activation of nuclear factor-κB p50 homodimer/Bcl3 complexes in nasopharyngeal carcinoma. Cancer Res. 63, 8293-8301.
24. Westerheide, S. D., Mayo, M. W., Anest, V., Hanson, J. L., Baldwin, A. S., Jr. (2001) The putative oncoprotein Bcl3 induces cyclin D1 to stimulate G(1) transition. Mol. Cell Biol. 21, 8428-8436.
25. Zhao, Y., Ramakrishnan, A., Kim, K. E., Rabson, A. B. (2005) Regulation of Bcl3 through interaction with the Lck tyrosine kinase. Biochem. Biophys. Res. Commun. 335, 865-873.